Figure 1.
Figure 1. IDH1MT reduce maximal IDH1/2 activity, but IDH1/2 is a more important NADPH producer in glioblastoma than in AML compared with G6PD.

IDH1MT reduce maximal IDH1/2 activity, but IDH1/2 is a more important NADPH producer in glioblastoma than in AML compared with G6PD.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal